GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ — Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones that broaden…
In this week’s issue of The Savvy Diabetic: FDA Approves Kristy – Biosimilar to Novolog Dexcom Responds to Sensor Failures & More ‘Ozempic Teeth’ GLP-1 Side Effect Innovations in Preventing/Treating…
This week's issue of The Savvy Diabetic: 3D printed islet transplantation Abvance therapy funded for next-generation glucagon analogs/therapies Glucotrack's CBGM Implant Technology The AX-4 Space Mission Study Glucose Metabolism and…
The U.S. Food and Drug Administration has approved the first generic version of Victoza (liraglutide injection), significantly improving access to diabetes treatment. Glucagon-like peptide-1 (GLP-1) receptor agonists are designed to…
June 15, 2024 by Holly Honderich, BBC News Getty Images Continuous glucose monitors have become a powerful tool for people with diabetes Blood glucose monitoring devices may soon be on…
Barchart.com Type 1 Diabetes Market Report 2032: Latest FDA, EMA, PDMA, Pipeline Therapies, EpidemiologyDelveInsight's “Type 1 Diabetes Market Insights, Epidemiology, Market Forecast – 2032” report provides a detailed understanding of…
Underlying technology A brief history of CGM CGM is a wearable technology that allows users to track their blood sugar levels in real time. Historically, people with type 1 or…
Fat-free or full-fat, flavored or plain, probiotic or natural, yogurt already has a label on it.But you may soon see a new label on your container: This month, the Food…
Smart watches and rings that claim to measure blood sugar levels for medical purposes without puncturing the skin can be potentially dangerous and should be avoided, the Food and Drug…
(WXYZ) — The FDA has cleared the first continuous blood glucose monitor available without a prescription. The device, called Stelo, is designed for people with type 2 diabetes who do…